NASDAQ:DRTS

Alpha Tau Medical Ltd.

Stock

USD

Last Close

2.13

26/07 20:00

Market Cap

152.16M

Beta: 1.03

Volume Today

5.60K

Avg: 36.38K

PE Ratio

−8.90

PFCF: −36.22

Overview Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-8.46M -	-8.88M 4.94%	-27.27M 207.04%	-33.76M 23.80%	-29.16M 13.64%
depreciation and amortization	66K -	86K 30.30%	776K 802.33%	979K 26.16%	1.07M 9.70%
deferred income tax	994K -	203K 79.58%	13.26M 6,430.54%		-8.93M -
stock based compensation	546K -	596K 9.16%	812K 36.24%	6.75M 731.03%	7.93M 17.46%
change in working capital	-64K -	899K 1,504.69%	585K 34.93%	-307K 152.48%	2.49M 911.73%
accounts receivables
inventory
accounts payables	148K -	114K 22.97%	239K 109.65%	220K 7.95%	1.14M 419.55%
other working capital	-212K -	785K 470.28%	346K 55.92%	-527K 252.31%	1.35M 355.98%
other non cash items	12K -	-153K 1,375%	29K 118.95%	2.46M 8,393.10%	8.64M 250.71%
net cash provided by operating activities	-6.91M -	-7.25M 4.93%	-11.81M 62.90%	-23.88M 102.16%	-17.96M 24.80%
investments in property plant and equipment	-1.29M -	-3.77M 191.34%	-2.93M 22.30%	-904K 69.12%	-6.40M 608.08%
acquisitions net	8.87K -		-22.20M -	-22.20M 0%	-28.23M 27.18%
purchases of investments	-54.27M -	-4.05M 92.54%	-8.08M 99.56%	-121.14M 1,398.85%	-163.63M 35.08%
sales maturities of investments	45.40M -	66.15M 45.70%	30.28M 54.22%	32.10M 6.02%	191.86M 497.61%
other investing activites	-8.87K -	-66.15M 745,672.27%	22.20M 133.56%	22.20M 0%	25.08M 12.99%
net cash used for investing activites	-10.16M -	-7.82M 23.08%	19.27M 346.55%	-89.94M 566.64%	18.68M 120.77%
debt repayment
common stock issued	5.25M -	29.32M 458.42%	111K 99.62%	3.36M 2,928.83%	49K 98.54%
common stock repurchased
dividends paid
other financing activites	73K -	29.32K 59.84%		93.54M -	5.25M 94.39%
net cash used provided by financing activities	5.32M -	29.32M 450.76%	111K 99.62%	96.91M 87,201.80%	5.30M 94.53%
effect of forex changes on cash	-18K -	84K 566.67%	108K 28.57%	-258K 338.89%	-50K 80.62%
net change in cash	-11.77M -	14.33M 221.80%	7.68M 46.42%	-17.17M 323.54%	9.12M 153.14%
cash at beginning of period	13.61M -	1.84M 86.47%	16.17M 778.54%	23.85M 47.48%	6.69M 71.97%
cash at end of period	1.84M -	16.17M 778.54%	23.85M 47.48%	6.69M 71.97%	15.81M 136.45%
operating cash flow	-6.91M -	-7.25M 4.93%	-11.81M 62.90%	-23.88M 102.16%	-17.96M 24.80%
capital expenditure	-1.29M -	-3.77M 191.34%	-2.93M 22.30%	-904K 69.12%	-6.40M 608.08%
free cash flow	-8.20M -	-11.02M 34.32%	-14.74M 33.77%	-24.78M 68.15%	-24.36M 1.71%

All numbers in USD (except ratios and percentages)